As of Sep 01
| -0.0209 / -2.11%|
The 1 analysts offering 12-month price forecasts for Enzon Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 16.00 and a low estimate of 16.00. The median estimate represents a +1,551.02% increase from the last price of 0.97.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.